I
Ilooda Co Ltd
KOSDAQ:164060
Ilooda Co Ltd
KOSDAQ:164060
Price:
7 090
KRW
Market Closed
Market Cap:
₩150.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Ilooda Co Ltd
KOSDAQ:164060
|
KR |
|
Humacyte Inc
NASDAQ:HUMA
|
US |
|
BMEX Gold Inc
XTSX:BMEX
|
CA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of Ilooda Co Ltd.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
Not Available
I
Multiples Across Competitors
Competitors Multiples
Ilooda Co Ltd Competitors
Ilooda Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
I
|
Ilooda Co Ltd
KOSDAQ:164060
|
148.7B KRW | 2.6 | -22 | 81.3 | -237.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182B USD | 4.1 | 28.1 | 16.1 | 22.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.9B USD | 16.7 | 58.9 | 44.7 | 54.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 5.1 | 39.3 | 20.1 | 24.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.8B USD | 3.2 | 24.6 | 13.6 | 19.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.5B USD | 5.2 | 36.1 | 21.2 | 28.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.5B EUR | 1.8 | 19.5 | 11 | 15.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD | 8 | 45.1 | 24.9 | 27.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.9B USD | 10.7 | 43.6 | 30.9 | 34.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.1B USD | 2.1 | 25.8 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33B USD | 6.1 | 22.1 | 15.5 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
